Condition
Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials and research
Research outlook What's coming for Diffuse large B-cell lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 3 Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Fecal transplant to restore gut microbiome before CAR T therapy for relapsed or refractory B‑cell lymphoma | Phase 2 | Duarte, California | Recruiting | Jun 29, 2025 |
| Epcoritamab with platinum chemotherapy and autologous stem cell transplant for relapsed or refractory large B-cell lymphoma | Phase 2 | Sacramento, California | Recruiting | Apr 1, 2025 |
| Odronextamab with CAR T‑cell therapy for relapsed or refractory diffuse large B‑cell lymphoma | Phase 2 | Sacramento, California | Recruiting | Mar 3, 2025 |
All recruiting trials (3)
-
Fecal transplant to restore gut microbiome before CAR T therapy for relapsed or refractory B‑cell lymphoma
This trial will test whether a fecal microbiome transplant can restore healthy gut bacteria and improve outcomes for adults with relapsed or refractory CD19 B‑cell lymphoma who received high‑risk antibiotics and are receiving CAR T‑cell therapy.
-
Epcoritamab with platinum chemotherapy and autologous stem cell transplant for relapsed or refractory large B-cell lymphoma
This trial tests whether adding epcoritamab to standard platinum-based salvage chemotherapy followed by an autologous stem cell transplant helps adults with relapsed or refractory large B-cell lymphoma.
-
Odronextamab with CAR T‑cell therapy for relapsed or refractory diffuse large B‑cell lymphoma
This trial tests whether giving odronextamab before or after CAR T‑cell therapy helps adults with diffuse large B‑cell lymphoma that has relapsed or not responded to prior treatments.
Related topics
Quick answers
How many Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.